Shanghai Institute of Materia Medica Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013328
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that offers research and development of traditional Chinese medicine. The institute provides solutions in the areas of drug discovery and drug development. It also provides studies of structure-activity relationships of bioactive substances, new chemical entities, pre-clinical evaluation and pharmaceutical development. SIMM develops drugs such as artemether, dimercaptosuccinic acid, and huperzine a, depsides salts, and antofloxacin hydrochloride. The institute carries out research in the areas of drug screening, pharmacology, medicinal chemistry, products chemistry, combinatorial chemistry, toxicology, pharmacokinetics and computer-aided drug design. SIMM is headquartered in Shanghai, China.

Shanghai Institute of Materia Medica Chinese Academy of Sciences – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Shandong Luoxin Pharma Enters into Agreement with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Fudan University 10
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 11
Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 12
Licensing Agreements 13
Servier Enters Into Licensing Agreement With Shanghai Institute Of Materia Medica 13
Asset Transactions 14
3SBio Acquires Patents For DJ5, Potential Renal Failure Therapy, From SIMM 14
Shanghai Institute of Materia Medica Chinese Academy of Sciences – Key Competitors 16
Shanghai Institute of Materia Medica Chinese Academy of Sciences – Key Employees 17
Shanghai Institute of Materia Medica Chinese Academy of Sciences – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Key Facts 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Deals By Therapy Area, 2011 to YTD 2017 8
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Shandong Luoxin Pharma Enters into Agreement with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Fudan University 10
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 11
Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 12
Servier Enters Into Licensing Agreement With Shanghai Institute Of Materia Medica 13
3SBio Acquires Patents For DJ5, Potential Renal Failure Therapy, From SIMM 14
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Key Competitors 16
Shanghai Institute of Materia Medica Chinese Academy of Sciences, Key Employees 17

★海外企業調査レポート[Shanghai Institute of Materia Medica Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PolyPid Ltd (POLY):医療機器:M&Aディール及び事業提携情報
    Summary PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reserv …
  • ScinoPharm Taiwan Ltd (1789):製薬・医療:M&Aディール及び事業提携情報
    Summary ScinoPharm Taiwan Ltd (ScinoPharm) provides process research and development (R&D) and active pharmaceutical ingredient (API) manufacturing services to the pharmaceutical industry. It services include custom synthesis for early phase pharmaceutical activities, brand companies and APIs for th …
  • Kemin Industries Inc:企業の戦略・SWOT・財務情報
    Kemin Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Kemin Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Omeros Corp (OMER):製薬・医療:M&Aディール及び事業提携情報
    Summary Omeros Corp (Omeros) is a biopharmaceutical company that discovers, develops and commercializes small-molecule and protein therapeutics for large-market and orphan indications. The company’s pipeline products include Omidria, a phenylephrine and ketorolac injection for use during cataract su …
  • Euro-Diagnostica AB-医療機器分野:企業M&A・提携分析
    Summary Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified reagents and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers product …
  • Suncor Energy Inc (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Suncor Energy Inc (Suncor) is an integrated energy company that mainly focuses on the development of Athabasca oil sands. It carries out development and up gradation of oil sands; offshore and onshore oil and gas production; refining of crude oil and marketing of petroleum and petrochemical …
  • REC Silicon ASA (REC)-エネルギー分野:企業M&A・提携分析
    Summary REC Silicon ASA (REC Silicon), formerly Renewable Energy Corporation ASA, produces and supplies advanced silicon materials. It offers solar grade polysilicon, electronic grade polysilicon, and silicon gases. Its products find application in the solar and electronics industries in the product …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Scorpio Tankers Inc (STNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Scorpio Tankers Inc. (Scorpio Tankers), a part of Scorpio Group, provides marine transportation of refined petroleum products and crude oil worldwide. The company operates through a network of owned and time chartered vessels, which distribute vegetable oils, petroleum-based feedstock and re …
  • Mitsubishi Heavy Industries, Ltd.:企業の戦略・SWOT・財務情報
    Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Ryman Healthcare Ltd (RYM):企業の財務・戦略的SWOT分析
    Ryman Healthcare Ltd (RYM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • The Baltimore Life Insurance Company:企業の戦略・SWOT・財務情報
    The Baltimore Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary The Baltimore Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Bionik Laboratories Corp (BNKL):医療機器:M&Aディール及び事業提携情報
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company provides rehabilitation technology that senses patient movements and limitations. It provides lower body …
  • Mitsubishi Estate Co., Ltd. (8802):企業の財務・戦略的SWOT分析
    Mitsubishi Estate Co., Ltd. (8802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Swinerton Inc:企業の戦略的SWOT分析
    Swinerton Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Clean Harbors, Inc. (CLH)-石油・ガス分野:企業M&A・提携分析
    Summary Clean Harbors, Inc. (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and insit …
  • Abu Dhabi Water & Electricity Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Water & Electricity Authority (ADWEA) is a government-owned organization provides utility services. The authority researches and develops methods for the production, distribution and consumption of water and electricity efficiently. Through subsidiaries, ADWEA conducts generation, …
  • Sempra U.S. Gas & Power LLC-石油・ガス分野:企業M&A・提携分析
    Summary Sempra U.S. Gas & Power, LLC (Sempra US), a subsidiary of Sempra Energy, an energy solution provider, is a clean power solutions developer. It develops, designs, constructs and operates renewable energy and natural gas solutions, with a focus on zero and low emission fuels. The company owns …
  • Versum Materials, Inc.:企業の戦略的SWOT分析
    Versum Materials, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Boustead Heavy Industries Corp Bhd:企業の戦略・SWOT・財務情報
    Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report Summary Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆